Financhill
Back

NovaBay Pharmaceuticals, Inc. Vs. Apogee Enterprises, Inc. Industry Stock Comparison

Buy
85

NBY
NovaBay Pharmaceuticals, Inc.

Last Price:
$9.49
Seasonality Move:
13.91%
Sell
40

APOG
Apogee Enterprises, Inc.

Last Price:
$33.75
Seasonality Move:
5.62%
Buy
85
NovaBay Pharmaceuticals, Inc. (NBY) is a Buy

Is NovaBay Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals, Inc. [NBY] share price is $10.64. The Score for NBY is 85, which is 70% above its historic median score of 50, and infers lower risk than normal.
  • NBY is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
40
Apogee Enterprises, Inc. (APOG) is a Sell

Is Apogee Enterprises, Inc. a Buy, Sell or Hold?

  • The current Apogee Enterprises, Inc. [APOG] share price is $33.77. The Score for APOG is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • APOG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals, Inc.'s stock price today?

  • The NovaBay Pharmaceuticals, Inc. share price today is $10.64
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing slight selling pressure.

APOG Stock Price Chart

What is Apogee Enterprises, Inc.'s stock price today?

  • The Apogee Enterprises, Inc. share price today is $33.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APOG is experiencing slight buying pressure.

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.65 Buy
Relative Strength Index (14 RSI): 86.71 Buy
Chaikin Money Flow: 2519680 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

APOG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.7 Sell
Relative Strength Index (14 RSI): 35.89 Sell
Chaikin Money Flow: 244445 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.92 - 39.76) Sell
Bollinger Bands (100): (35.93 - 43.19) Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.39 Buy
20-day SMA: 4.5 Buy
50-day SMA: 2.45 Buy
200-day SMA: 1.33 Buy
8-day EMA: 6.9 Buy
20-day EMA: 5.01 Buy
50-day EMA: 3.15 Buy
200-day EMA: 1.18 Buy

APOG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.04 Sell
20-day SMA: 37.95 Sell
50-day SMA: 36.64 Sell
200-day SMA: 40.8 Sell
8-day EMA: 35.7 Sell
20-day EMA: 36.87 Sell
50-day EMA: 37.57 Sell
200-day EMA: 42.57 Sell

NovaBay Pharmaceuticals, Inc. Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and a decrease next year of $0.00 per share.

Apogee Enterprises, Inc. Earnings Growth & APOG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, an increase next quarter of $0.12 per share, a decrease this year of $1.42 per share, and a decrease next year of $0.04 per share.

NovaBay Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apogee Enterprises, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):